Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
golimumab (simponi) (1 trial)
naltrexone (revia) (1 trial)
donor regulatory t lymphocytes (1 trial)
Arthritis (Phase 3)
Arthritis, Psoriatic (Phase 3)
Graft vs Host Disease (Phase 2)
Trials (2 total)
Trial APIs (3 total)